HyperBranch Signs BD Deal
Durham-based HyperBranch Medical Technology, a 6-year-old medical device company that develops sealants for surgical use, has reached a marketing deal on its OcuSeal liquid eye bandage that lets Becton, Dickinson sell the product worldwide.
HyperBranch, which employs a dozen people, has been selling OcuSeal, its first product, through independent distributors overseas since it was cleared by European regulators in 2007, but it's still being evaluated by the U.S. Food and Drug Administration.
"OcuSeal is a significant improvement for a variety of ophthalmic procedures," said John Conn, HyperBranch president and CEO, "and BD is an excellent partner to offer this technology to a wider market. The transaction with an industry leader like BD further validates our platform technology, and in a very sensitive field of use."
HyperBranch has applied to the FDA for other product approvals for use in brain and spine surgery and for the fixation of mesh during hernia repair. The company also plans to introduce products into the cardiovascular and minimally invasive surgery markets.